• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Afya Limited

    3/4/25 4:35:34 PM ET
    $AFYA
    Other Consumer Services
    Real Estate
    Get the next $AFYA alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 33)


    Afya Ltd

    (Name of Issuer)


    Class A Common Shares, par value $0.00005 per share

    (Title of Class of Securities)


    G01125106

    (CUSIP Number)


    Denise Abel
    Bertelsmann SE & Co. KGaA, Carl-Bertelsmann-Strasse 270
    Gutersloh, 2M, 33311
    49-0-5241-80-2551


    Michael Davis, Esq.
    Davis Polk & Wardwell LLP, 450 Lexington Avenue
    New York, NY, 10017
    212-450-4184

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    02/28/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    G01125106


    1 Name of reporting person

    Bertelsmann SE & Co. KGaA
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    GERMANY
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    60,650,713.00
    9Sole Dispositive Power

    60,650,713.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    60,650,713.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    75.34 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    With reference to Row 11: Aggregate amount beneficially owned by Bertelsmann SE & Co. KGaA (Bertelsmann) and Erste WV Gutersloh GmbH, a wholly-owned direct subsidiary of Bertelsmann (Erste, and collectively with Bertelsmann, the Reporting Person) consists of 34,074,134 Class B common shares and 26,576,579 Class A common shares held of record by the Reporting Person. Each Class B common share held of record by the Reporting Person is convertible into one Class A common share at the option of its holder at any time. With reference to Row 13: Represents the quotient obtained by dividing (a) the number of Class B common shares and Class A common shares beneficially owned by the Reporting Person as set forth in Row 11 by (b) the sum of (i) 46,426,830 Class A common shares outstanding as of September 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Securities and Exchange Commission (the Commission) on November 13, 2024 (as reduced by the number of treasury shares reported therein), and (ii) the aggregate number of Class B common shares beneficially owned by the Reporting Person. The aggregate number of Class B common shares beneficially owned by the Reporting Person as set forth in clauses (a) and (b) of this footnote are treated as converted into Class A common shares only for the purpose of computing the percentage ownership of the Reporting Person. As of September 30, 2023, the number of Class A common shares outstanding was 44,009,699 and the percentage beneficially owned was 58.06%. With reference to Row 13: Each Class A common share is entitled to one vote, and each Class B common share is entitled to ten votes. The percentage reported does not reflect the ten for one voting power of the Class B common shares because the Class B common shares are treated as converted into Class A common shares for the purpose of this report.


    SCHEDULE 13D

    CUSIP No.
    G01125106


    1 Name of reporting person

    Erste WV Gutersloh GmbH
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    GERMANY
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    60,650,713.00
    9Sole Dispositive Power

    60,650,713.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    60,650,713.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    75.34 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    With reference to Row 11: Aggregate amount beneficially owned by Bertelsmann SE & Co. KGaA (Bertelsmann) and Erste WV Gutersloh GmbH, a wholly-owned direct subsidiary of Bertelsmann (Erste, and collectively with Bertelsmann, the Reporting Person) consists of 34,074,134 Class B common shares and 26,576,579 Class A common shares held of record by the Reporting Person. Each Class B common share held of record by the Reporting Person is convertible into one Class A common share at the option of its holder at any time. With reference to Row 13: Represents the quotient obtained by dividing (a) the number of Class B common shares and Class A common shares beneficially owned by the Reporting Person as set forth in Row 11 by (b) the sum of (i) 46,426,830 Class A common shares outstanding as of September 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Securities and Exchange Commission (the Commission) on November 13, 2024 (as reduced by the number of treasury shares reported therein), and (ii) the aggregate number of Class B common shares beneficially owned by the Reporting Person. The aggregate number of Class B common shares beneficially owned by the Reporting Person as set forth in clauses (a) and (b) of this footnote are treated as converted into Class A common shares only for the purpose of computing the percentage ownership of the Reporting Person. As of September 30, 2023, the number of Class A common shares outstanding was 44,009,699 and the percentage beneficially owned was 58.06%. With reference to Row 13: Each Class A common share is entitled to one vote, and each Class B common share is entitled to ten votes. The percentage reported does not reflect the ten for one voting power of the Class B common shares because the Class B common shares are treated as converted into Class A common shares for the purpose of this report.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A Common Shares, par value $0.00005 per share
    (b)Name of Issuer:

    Afya Ltd
    (c)Address of Issuer's Principal Executive Offices:

    ALAMEDA OSCAR NIEMEYER, NO. 119, 15TH FLOOR, VILA DA SERRA, NOVA LIMA, MINAS GERAIS, BRAZIL , 34006-056.
    Item 1 Comment:
    Explanatory Note This Amendment No. 33 (the "Amendment") amends and supplements the Schedule 13D filed by the Reporting Person on August 10, 2021 (the "Original Schedule 13D", as further amended on March 4, 2022, "Amendment No. 1", as further amended on April 18, 2022, "Amendment No. 2", as further amended on April 25, 2022, "Amendment No. 3," as further amended on May 4, 2022, "Amendment No. 4," as further amended on May 23, 2022, "Amendment No. 5," as further amended on May 27, 2022, "Amendment No. 6," as further amended on August 1, 2022, "Amendment No. 7," as further amended on August 31, 2022, "Amendment No. 8," as further amended on September 23, 2022, "Amendment No. 9," as further amended on October 24, 2022, "Amendment No. 10," as further amended on November 9, 2022, "Amendment No. 11," as further amended on November 29, 2022, "Amendment No. 12," as further amended on December 16, 2022, "Amendment No. 13," as further amended on December 21, 2022, "Amendment No. 14," as further amended on January 12, 2023, "Amendment No. 15," as further amended on February 23, 2023, "Amendment No. 16," as further amended on March 29, 2023, "Amendment No. 17," as further amended on May 1, 2023, "Amendment No. 18," as further amended on June 20, 2023, "Amendment No. 19," as further amended on July 25, 2023, "Amendment No. 20," as further amended on September 7, 2023, "Amendment No. 21," as further amended on October 31, 2023, "Amendment No. 22," as further amended on December 12, 2023, "Amendment No. 23," as further amended on February 12, 2024, "Amendment No. 24," as further amended on March 19, 2024, "Amendment No. 25," as further amended on May 7, 2024, "Amendment No. 26," as further amended on May 22, 2024, "Amendment No. 27," as further amended on June 27, 2024, "Amendment No. 28," as further amended on July 23, 2024, "Amendment No. 29," as further amended on September 18, 2024, "Amendment No. 30," as further amended on October 31, 2024, "Amendment No. 31," as further amended on December 20, 2024, "Amendment No. 32," and, as amended and supplemented by this Amendment, the "Schedule 13D"). Except as specifically provided herein, this Amendment does not modify any of the information previously reported on the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 13, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 27, Amendment No. 28, Amendment No. 29, Amendment No. 30, Amendment No. 31 or Amendment No. 32. Capitalized terms not otherwise defined in this Amendment shall have the same meanings ascribed thereto in the Original Schedule 13D. This Schedule 13D relates to the Class A common shares, par value $0.00005, of Afya Limited, an exempted liability company incorporated under the laws of the Cayman Islands (the "Issuer"), having its registered offices at Alameda Oscar Niemeyer, No. 119, Salas 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas Gerais Brazil.
    Item 3.Source and Amount of Funds or Other Consideration
     
    This Amendment No. 33 amends and supplements Item 3 of the Original Schedule 13D (as amended by Amendment No. 3, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30, Amendment No. 31 and Amendment No. 32) as follows: The Reporting Person purchased an additional 918,877 Class A common shares pursuant to the Trading Plan for a purchase price of $14,998,794.17, or an average of $16.32 per Class A common share. Such price was funded by the Reporting Person through internally generated funds.
    Item 5.Interest in Securities of the Issuer
    (a)
    This Amendment No. 33 amends and supplements Item 5 of the Original Schedule 13D (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30, Amendment No. 31 and Amendment No. 32) as follows: The information relating to the beneficial ownership of Class A common shares by the Reporting Person as set forth in rows 7 through 13 of the cover pages hereto is incorporated by reference. The Reporting Person is the beneficial owner of 26,576,579 Class A common shares, which represents 57.24% of the Class A common shares outstanding based on 46,426,830 Class A common shares outstanding as of September 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Commission on November 13, 2024 (as reduced by the number of treasury shares reported therein). Except as set forth in this Item 5(a), the Reporting Person does not own beneficially any Class A common shares. The Reporting Person will provide upon request of the SEC staff the full information regarding the number of shares purchased or sold at each separate price.
    (b)
    This Amendment No. 33 amends and supplements Item 5 of the Original Schedule 13D (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30, Amendment No. 31 and Amendment No. 32) as follows: The Reporting Person has shared power to vote and dispose of 26,576,579 Class A common shares.
    (c)
    This Amendment No. 33 amends and supplements Item 5 of the Original Schedule 13D (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 28, Amendment No. 29, Amendment No. 30, Amendment No. 31 and Amendment No. 32) as follows: The Reporting Person has purchased the following Class A common shares in open market transactions pursuant to the Trading Plan since the filing of the Schedule 13D/A on December 20, 2024: Transaction Date Class A Common Shares Purchased Average Price Per Share December 19, 2024 20,168 15.09 December 20, 2024 25,682 15.61 December 23, 2024 24,058 15.42 December 24, 2024 16,958 15.70 December 26, 2024 27,788 15.94 December 27, 2024 27,788 15.83 December 30, 2024 27,630 15.83 December 31, 2024 27,439 15.96 January 8, 2025 23,955 15.06 January 10, 2025 21,570 14.96 January 13, 2025 20,837 15.22 January 14, 2025 22,473 15.23 January 15, 2025 21,446 15.52 January 16, 2025 16,336 15.67 January 17, 2025 22,473 15.83 January 21, 2025 13,654 15.77 January 22, 2025 18,541 15.78 January 23, 2025 15,014 15.77 January 24, 2025 18,541 16.32 January 27, 2025 19,280 16.63 January 28, 2025 18,951 16.66 January 29, 2025 18,500 16.32 January 30, 2025 19,280 16.57 January 31, 2025 17,563 16.13 February 3, 2025 19,160 16.00 February 4, 2025 19,352 16.43 February 5, 2025 21,543 16.13 February 6, 2025 21,543 16.44 February 7, 2025 21,125 16.65 February 10, 2025 21,410 16.74 February 11, 2025 21,543 16.71 February 12, 2025 21,543 16.89 February 13, 2025 21,543 17.13 February 14, 2025 19,266 17.57 February 18, 2025 23,860 17.86 February 19, 2025 17,670 17.94 February 20, 2025 23,860 17.68 February 21, 2025 23,860 17.39 February 24, 2025 23,216 17.15 February 25, 2025 24,726 17.39 February 26, 2025 24,726 16.91 February 27, 2025 22,469 17.03 February 28, 2025 20,537 16.86

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Bertelsmann SE & Co. KGaA
     
    Signature:ppa /s/ Martin Dannhoff
    Name/Title:Martin Dannhoff, SVP Corporate Legal
    Date:03/04/2025
     
    Signature:ppa /s/ Denise Abel
    Name/Title:Denise Abel, SVP Corporate Legal
    Date:03/04/2025
     
    Erste WV Gutersloh GmbH
     
    Signature:/s/ Martin Dannhoff
    Name/Title:Martin Dannhoff, Director
    Date:03/04/2025
     
    Signature:/s/ Denise Abel
    Name/Title:Denise Abel, Director
    Date:03/04/2025
    Get the next $AFYA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFYA

    DatePrice TargetRatingAnalyst
    1/16/2026$16.00Buy → Neutral
    UBS
    1/7/2026$22.00Overweight → Neutral
    Analyst
    9/8/2025$24.50Neutral → Overweight
    Analyst
    9/8/2025$19.00Neutral → Buy
    UBS
    8/6/2025$17.50Underweight → Overweight
    Morgan Stanley
    7/29/2025$14.00Sell → Neutral
    Citigroup
    3/11/2025$19.00 → $17.00Equal-Weight → Underweight
    Morgan Stanley
    1/31/2025$18.00 → $15.00Neutral → Sell
    Citigroup
    More analyst ratings

    $AFYA
    SEC Filings

    View All

    SEC Form 6-K filed by Afya Limited

    6-K - Afya Ltd (0001771007) (Filer)

    2/6/26 8:11:55 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Afya Limited

    6-K - Afya Ltd (0001771007) (Filer)

    12/17/25 4:43:09 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    SEC Form S-8 filed by Afya Limited

    S-8 - Afya Ltd (0001771007) (Filer)

    11/12/25 5:26:20 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Afya Limited Announces Medical Seats Increase in Afya Abaetetuba

    Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and provider of medical practice solutions in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") has authorized an increase of 63 medical seats for ITPAC – Instituto Tocantinense Presidente Antonio Carlos Porto S.A. ("Afya Abaetetuba"), located in the city of Abaetetuba, in the state of Pará. With this authorization, Afya's Abaetetuba campus will offer a total of 113 medical seats. As Afya Cametá—an approved but, non-operating medical school —and Afya Abaetetuba are located within the same health region, Afya

    2/6/26 8:38:00 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Announces Changes to Its Board of Directors

    Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that Mrs. Maria Tereza Azevedo notified the Company of her intent to resign as a member of the Board of Directors of the Company, effective as of December 31, 2025. Afya thanks Maria Tereza for her dedication and meaningful contributions to the Board and wishes her continued success in her future endeavors. Afya's Board of Directors is composed of two co-chairmen - one representing Bertelsmann SE&Co. KGaA, and one representing the Esteves family -, one more member of the Esteves family, two more members of Bertelsmann SE&C

    12/17/25 5:22:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces Third Quarter and Nine Months 2025 Financial Results

    Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2025 (third quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2025 Highlights 3Q25 Revenue increased 10.4% YoY to R$928.5 million. Revenue excluding acquisitions increased 10.1%, reaching R$926.2 million.

    11/12/25 6:12:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Afya downgraded by UBS with a new price target

    UBS downgraded Afya from Buy to Neutral and set a new price target of $16.00

    1/16/26 8:27:35 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya downgraded by Analyst with a new price target

    Analyst downgraded Afya from Overweight to Neutral and set a new price target of $22.00

    1/7/26 8:52:58 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya upgraded by Analyst with a new price target

    Analyst upgraded Afya from Neutral to Overweight and set a new price target of $24.50

    9/8/25 8:32:46 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Leadership Updates

    Live Leadership Updates

    View All

    Afya Limited Announces Results of Annual General Meeting Held on June 24, 2025

    Afya Limited, or "Afya" (NASDAQ:AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated June 9, 2025 was duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2024; (2) the re-appointment of João Paulo Seibel de Faria as an independent director of the Company with immediate effect to hold office for a two year term; (3) the re-appointment of Vanessa Claro Lopes as an independent director of the Company with immediate effect to hold office for a two year term; (4) the re-appointment of Miguel Filisbino Pereira de Paula as an independent di

    6/24/25 5:52:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces that Whitebook was ranked as one of the 10 Top Apps in Brazil by Consumer Spend in 2020

    NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announces that its clinical decision software, WhiteBook, an app created by PEBMED, was ranked as one of the 10 Top Apps in Brazil by consumer spend in 2020 for the fifth year in a row. App Annie conducted the study, a website specialized in app analytics and app market data that combined data from iOS and Google Play that evaluates more than 8 million mobile app per year. In the top ten WhiteBook was among great apps such as Tinder, YouTube, Netflix, TikTok and others. Whitebook is a mobile and web application software that helps doctors and medical students to make

    1/15/21 8:55:10 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Financials

    Live finance-specific insights

    View All

    Afya Limited Announces Third Quarter and Nine Months 2025 Financial Results

    Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2025 (third quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2025 Highlights 3Q25 Revenue increased 10.4% YoY to R$928.5 million. Revenue excluding acquisitions increased 10.1%, reaching R$926.2 million.

    11/12/25 6:12:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces Second-Quarter and First-Half 2025 Financial Results

    Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2025 (second quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second-Quarter 2025 Highlights 2Q25 Revenue increased 13.5% YoY to R$919.4 million. Revenue excluding acquisitions increased 8.5%, reaching R$879.0 million. 2

    8/13/25 6:03:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya Limited Announces a New Share Repurchase Program

    Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning from August 15, 2025 until the earlier of the completion of the repurchase or December 31, 2026, depending upon market conditions. The share purchases may be made from time to time through open market transactions and are subject to marke

    8/13/25 4:48:00 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    $AFYA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Afya Limited

    SC 13G/A - Afya Ltd (0001771007) (Subject)

    11/14/24 5:15:03 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Afya Limited

    SC 13G/A - Afya Ltd (0001771007) (Subject)

    11/14/24 4:21:17 PM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Afya Limited

    SC 13G/A - Afya Ltd (0001771007) (Subject)

    11/14/24 4:18:15 PM ET
    $AFYA
    Other Consumer Services
    Real Estate